Pulse Biosciences Statistics
Total Valuation
PLSE has a market cap or net worth of $1.00 billion. The enterprise value is $863.77 million.
Important Dates
The last earnings date was Wednesday, October 30, 2024, after market close.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PLSE has 61.52 million shares outstanding. The number of shares has increased by 23.82% in one year.
| Current Share Class | 61.52M |
| Shares Outstanding | 61.52M |
| Shares Change (YoY) | +23.82% |
| Shares Change (QoQ) | +6.80% |
| Owned by Insiders (%) | 71.08% |
| Owned by Institutions (%) | 7.99% |
| Float | 17.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 11.81 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.93, with a Debt / Equity ratio of 0.11.
| Current Ratio | 11.93 |
| Quick Ratio | 11.72 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.12 |
Financial Efficiency
Return on equity (ROE) is -70.28% and return on invested capital (ROIC) is -40.70%.
| Return on Equity (ROE) | -70.28% |
| Return on Assets (ROA) | -38.15% |
| Return on Capital (ROIC) | -40.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$823,804 |
| Employee Count | 56 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +209.55% in the last 52 weeks. The beta is 1.75, so PLSE's price volatility has been higher than the market average.
| Beta (5Y) | 1.75 |
| 52-Week Price Change | +209.55% |
| 50-Day Moving Average | 17.31 |
| 200-Day Moving Average | 12.77 |
| Relative Strength Index (RSI) | 40.17 |
| Average Volume (20 Days) | 122,644 |
Short Selling Information
The latest short interest is 2.75 million, so 4.47% of the outstanding shares have been sold short.
| Short Interest | 2.75M |
| Short Previous Month | 2.77M |
| Short % of Shares Out | 4.47% |
| Short % of Float | 15.97% |
| Short Ratio (days to cover) | 18.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -48.53M |
| Pretax Income | -42.55M |
| Net Income | -46.13M |
| EBITDA | -47.33M |
| EBIT | -48.53M |
| Earnings Per Share (EPS) | -$0.83 |
Full Income StatementBalance Sheet
The company has $79.03 million in cash and $8.37 million in debt, giving a net cash position of $70.67 million or $1.15 per share.
| Cash & Cash Equivalents | 79.03M |
| Total Debt | 8.37M |
| Net Cash | 70.67M |
| Net Cash Per Share | $1.15 |
| Equity (Book Value) | 79.13M |
| Book Value Per Share | 1.29 |
| Working Capital | 73.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$33.98 million and capital expenditures -$115,000, giving a free cash flow of -$34.10 million.
| Operating Cash Flow | -33.98M |
| Capital Expenditures | -115,000 |
| Free Cash Flow | -34.10M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |